Beginning with reports filed in the first quarter of fiscal 2022, the Company will reflect a refined methodology used in classifying certain indirect costs in accordance with the way the Company's management will use the information in decision making, which we believe will provide a more meaningful representation of costs incurred to support research and development activities. Future reports will also reflect a refined methodology used to allocate certain selling, general, and administrative expenses to the segments in a more direct manner to provide a more meaningful representation of segment profit or loss.
These changes in classification and allocation had no effect on the Company's consolidated operating or net income or on the Company's composition of operating segments and reportable segments. The Company expects to report its financial results in accordance with these changes beginning with the Company's first quarter 2022 Form 10-Q and will recast prior periods to conform to the revised presentation.
We estimate the expense classification change will result in a decrease to research and development expense of approximately $61 million, with a corresponding increase to selling, general, and administrative expenses, for the recast fiscal year ended December 25, 2021.
We estimate the segment allocation change will result in the following impacts to segment operating income for the recast fiscal year ended December 25, 2021:
|
|
52-Weeks Ended December 25, 2021 (In millions) |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
Auto |
|
|
||||
|
|
Fitness |
|
Outdoor |
|
Aviation |
|
Marine |
|
Total Auto |
|
Consumer Auto |
|
Auto OEM |
|
Total |
Operating income (decrease) increase |
|
$ (13) |
|
$ (5) |
|
$ 1 |
|
$ 6 |
|
$ 11 |
|
$ 3 |
|
$ 8 |
|
$ — |
Non-GAAP Financial Information
To supplement our financial results presented in accordance with GAAP, this release includes the following measures defined by the Securities and Exchange Commission as non-GAAP financial measures: pro forma effective tax rate, pro forma net income (earnings) per share and free cash flow. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP measures used by other companies, limiting the usefulness of the measures for comparison with other companies. Management believes providing investors with an operating view consistent with how it manages the Company provides enhanced transparency into the operating results of the Company, as described in more detail by category below.
The tables below provide reconciliations between the GAAP and non-GAAP measures.
Pro forma effective tax rate
The Company’s income tax expense is periodically impacted by discrete tax items that are not reflective of income tax expense incurred as a result of current period earnings. Therefore, management believes disclosure of the effective tax rate and income tax provision before the effect of certain discrete tax items are important measures to permit investors' consistent comparison between periods.
(In thousands, except ETR information) |
|
13-Weeks Ended |
|
|
52-Weeks Ended |
|
||||||||||||||||||||||||||
|
|
December 25, |
|
|
December 26, |
|
|
December 25, |
|
|
December 26, |
|
||||||||||||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||||||||||||||||||
|
|
$ |
|
|
ETR (1) |
|
|
$ |
|
|
ETR (1) |
|
|
$ |
|
|
ETR (1) |
|
|
$ |
|
|
ETR (1) |
|
||||||||
U.S GAAP income tax provision |
|
$ |
22,702 |
|
|
7.4% |
|
|
$ |
57,918 |
|
|
14.8% |
|
|
$ |
124,596 |
|
|
10.3% |
|
|
$ |
111,086 |
|
|
10.1% |
|
||||
Pro forma discrete tax items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Uncertain tax reserve release (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,308 |
|
|
|
|
|
Switzerland deferred tax assets (3) |
|
|
|
|
|
|
|
|
|
|
(11,016 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,016 |
) |
|
|
|
|
Pro forma income tax provision |
|
$ |
22,702 |
|
|
7.4% |
|
|
$ |
46,902 |
|
|
12.0% |
|
|
$ |
124,596 |
|
|
10.3% |
|
|
$ |
114,378 |
|
|
10.4% |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Effective tax rate is calculated by taking the income tax provision divided by income before taxes, as presented on the face of the Condensed Consolidated Statements of Income. |
|
|||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) In second quarter 2020, the Company recognized a $14.3 million income tax benefit due to the release of uncertain tax position reserves associated with the 2014 intercompany restructuring, which was a pro forma adjustment in 2014. The second quarter 2020 impact of the reserve release is not reflective of income tax expense incurred as a result of current period earnings and therefore affects period-to-period comparability. |
|
|||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) Certain Switzerland deferred tax assets related to the enactment of Switzerland Federal and Schaffhausen cantonal tax reform and related transitional measures were revalued in the fourth quarter of 2020 resulting in $11.0 million income tax expense. The impact of the revaluation of these Switzerland deferred tax assets is not reflective of income tax expense incurred as a result of current period earnings and therefore affects period-to-period comparability. |
|